August 16, 2022

From the Co-Chairs, August 2022

President Biden to appoint Dr. Monica Bertagnolli as NCI Director; NCI-MATCH trial data leads to FDA drug approval
August 16, 2022

NCI-MATCH precision medicine trial leads to FDA drug approval for BRAF V600E-mutated tumors

Dabrafenib/trametinib is the first and only BRAF/MEK inhibitor combination to be approved with a tumor-agnostic indication for solid tumors carrying the BRAF V600E mutation
August 16, 2022

Trial Spotlight: Neha Vapiwala on the EA8191/INDICATE Study for Prostate Cancer

This phase III study is using PET/CT imaging to guide treatment for patients with post-prostatectomy biochemical recurrence
August 16, 2022

Institution Spotlight: Penn State Cancer Institute

A Standing Main Member of ECOG-ACRIN since 2002
August 16, 2022

News in Brief, August 2022

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
June 21, 2022

From the Co-Chairs, June 2022

Reflections on the spring conference season, including highlights from the Spring Group Meeting and ASCO's Annual Meeting
June 21, 2022

Now Enrolling: EA9213 for T-Cell Acute Lymphoblastic Leukemia

This single-arm phase II study aims to rid patients of residual disease following initial treatment
June 21, 2022

ECOG-ACRIN Names University of Pennsylvania’s Jennifer Eads As Its Young Investigator of the Year

The Group is recognizing Dr. Eads as an exceptional medical oncologist and committed educator who is making significant research contributions as an international disease expert in neuroendocrine tumors and gastroesophageal malignancies
June 21, 2022

ECOG-ACRIN Research at ASCO 2022

ECOG-ACRIN researchers presented a wide range of study results at the 2022 ASCO Annual Meeting
June 21, 2022

Trial Spotlight Video: The EA8192 Study Team Discusses Their Trial for High Grade Upper Tract Urothelial Cancer

This study seeks to determine if neoadjuvant treatment with durvalumab and chemotherapy improves patient outcomes over chemotherapy alone
June 21, 2022

News in Brief, June 2022

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
April 15, 2022

From the Co-Chairs, April 2022

Congress creates a new health care research agency; NCI-MATCH continues to offer treatment options; ECOG-ACRIN plans for first in-person Group Meeting since 2019